Want to see AU:VIT full AI Analyst Report?

Cronos Australia Ltd. (VIT) Price & Analysis

18 Followers

VIT Stock Chart & Stats

AU$0.03

>-AU$0.01(-6.67%)

At close: Jul 27 4:00 PM EDT

AU$0.03

>-AU$0.01(-6.67%)

Day’s Range― - ―

52-Week RangeAU$0.02 - AU$0.07

Previous CloseN/A

Volume435.95K

Average Volume (3M)296.37K

Market Cap

AU$17.89M

Enterprise ValueAU$27.00

Total Cash (Recent Filing)AU$5.35M

Total Debt (Recent Filing)AU$16.40M

Price to Earnings (P/E)―

Beta1.47

Next Earnings

Mar 02, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield7.41%

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding662,741,800

10 Day Avg. Volume415,300

30 Day Avg. Volume296,373

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)0.38

Price to Sales (P/S)0.13

P/FCF Ratio-76.41

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth And Operating ScaleContinued revenue expansion indicates the company has built meaningful operating scale and market reach. Although growth alone does not offset current margin pressure, a larger revenue base can support future profitability if execution and cost control improve.

Solid Balance Sheet And Manageable LeverageA comparatively sound capital structure provides resilience through earnings volatility and reduces immediate financial stress. The equity base and manageable leverage give Cronos Australia flexibility to fund operations while it works to restore profitability.

Historical Cash Conversion CapabilitySeveral years of positive cash generation show that the business has previously converted earnings into liquidity effectively. This established capability is a potential foundation for recovery, provided operating performance stabilizes and the latest cash-flow reversal proves temporary.

Bears Say

Sharp Profitability DeteriorationThe move from profit to loss signals substantial margin pressure and weakens earnings quality. Persistent gross-profit deterioration could constrain reinvestment, reduce financial flexibility, and make future results more volatile until operating economics recover.

Negative Operating And Free Cash FlowNegative operating and free cash flow indicate that current operations are not funding the business adequately. If sustained, Cronos Australia may need additional financing or working-capital support, reducing the durability of earnings and limiting investment capacity.

Rising Debt And Declining Equity CushionHigher debt combined with lower equity reduces the balance-sheet cushion just as profitability and cash generation weaken. This raises financial risk over the medium term and could restrict strategic flexibility if losses or negative cash flow continue.

Cronos Australia Ltd. News

Vitura hit by BUPA telehealth shift but reiterates FY2027 growth outlook

Cronos Australia Ltd. ( ($AU:VIT) ) just unveiled an announcement. Vitura Health has disclosed a material setback for...

3h ago

VIT

Vitura Health pivots to disciplined growth after profit slump in FY2026

Cronos Australia Ltd. ( ($AU:VIT) ) has shared an update. Vitura reported FY2026 operating revenue of $131.2 million,...

12d ago

VIT

Vitura Health Files 2026 Corporate Governance Statement with ASX

Cronos Australia Ltd. ( ($AU:VIT) ) has shared an update. Vitura Health Limited has lodged its annual corporate...

12d ago

VIT

Vitura Health Slips to Loss as Cannabis Price Compression Squeezes Margins

Cronos Australia Ltd. ( ($AU:VIT) ) has issued an update. Vitura Health reported a consolidated loss after tax...

12d ago

VIT

Vitura Health Tightens Capital Structure as Rights and Options Lapse

Cronos Australia Ltd. ( ($AU:VIT) ) has provided an update. Vitura Health Limited has notified the market of...

1M ago

VIT

Vitura reshapes leadership team to cut costs and sharpen patient focus

Cronos Australia Ltd. ( ($AU:VIT) ) has issued an update. Vitura Health Limited has announced two senior appointments...

2M ago

VIT

Vitura Health Updates Corporate Address as Digital Health Network Expands

Cronos Australia Ltd. ( ($AU:VIT) ) has provided an announcement. Vitura Health Limited has updated its registered office...

2M ago

VIT

Vitura installs interim CFO as CEO launches finance leadership overhaul

Cronos Australia Ltd. ( ($AU:VIT) ) just unveiled an announcement. Vitura Health has appointed former long-serving finance chief...

3M ago

VIT

Vitura Health locks in $2.7m cost savings as growth initiatives gather pace

Cronos Australia Ltd. ( ($AU:VIT) ) has provided an announcement. Vitura Health has outlined a business transformation that...

4M ago

VIT

Vitura’s Doctors on Demand Hits 1 Million Consultations and Turns Profitable

The latest update is out from Cronos Australia Ltd. ( ($AU:VIT) ). Vitura Health’s Doctors on Demand telehealth...

5M ago

VIT

VIT FAQ

What was Cronos Australia Ltd.’s price range in the past 12 months?

Cronos Australia Ltd. lowest share price was AU$0.02 and its highest was AU$0.07 in the past 12 months.

What is Cronos Australia Ltd.’s market cap?

Cronos Australia Ltd.’s market cap is AU$17.89M.

When is Cronos Australia Ltd.’s upcoming earnings report date?

Cronos Australia Ltd.’s upcoming earnings report date is Mar 02, 2027 which is in 176 days.

How were Cronos Australia Ltd.’s earnings last quarter?

Cronos Australia Ltd. released its earnings results on Aug 25, 2026. The company reported -AU$0.005 earnings per share for the quarter.

Is Cronos Australia Ltd. overvalued?

According to Wall Street analysts Cronos Australia Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Cronos Australia Ltd. pay dividends?

Cronos Australia Ltd. pays a Notavailable dividend of AU$0.002 which represents an annual dividend yield of 7.41%. See more information on Cronos Australia Ltd. dividends here

What is Cronos Australia Ltd.’s EPS estimate?

Cronos Australia Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Cronos Australia Ltd. have?

Cronos Australia Ltd. has 662,741,800 shares outstanding.

What happened to Cronos Australia Ltd.’s price movement after its last earnings report?

Cronos Australia Ltd. reported an EPS of -AU$0.005 in its last earnings report. Following the earnings report the stock price went down -16.129%.

Which hedge fund is a major shareholder of Cronos Australia Ltd.?

Currently, no hedge funds are holding shares in AU:VIT

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Cronos Australia Ltd. Stock Smart Score

Underperform

Fundamentals

Return on Equity

7.41%

Trailing 12-Months

Asset Growth

1.65%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Cronos Australia Ltd.

Established in 2018 and based in South Yarra, Australia, Vitura Health Limited focuses on the supply and marketing of medicinal cannabis goods throughout Australia and the Asian market. The company manages a portfolio of key brands, such as CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. This entity was formerly recognized as Cronos Australia Limited before adopting the name Vitura Health Limited in February 2023.